i just expecting post-catalyst action similar to RMTI from what i'm reading on biod twitter. i think i'm going to make bank on a low-pop, bounce to big run. resistance lvls are $6 and $8, hilariously that's the same as it was for RMTI. i'm all over this Co, but i hate to see rookies lose money on complete nonsensical bear arguments that have no bearing on the low mcap of BIOD. If BIOD had a shot of showing superiority results, it would've been trading at a mcap of $500M before today's results, and then become a billion dollar company on monday. But no, the whole point of the bull thesis was that it would show non-inf in P2, MAYBE show some stat sig secondary endpoints (it did infact have at least 1 i think), but mostly show just positive trends, in which point P3 will be designed with p2 data in hand... P3 results will differentiate it from humalog, hopefully, and suddenly BIOD has a shot of capturing meaningful market share. Right now it trading below 1% market share. With good P3 results it will trade at least 5%, or, over $500M mcap... Fair value of BIOD did NOT go down today, l-m-a-o.
Was that a serious question? No longs on this MB delude themselves into thinking that BIO123 will be on store shelves next week. The idea that they have worked hard enough to get to this stage is probably going to be enough reward since I own it at $4. and change. Very recently purchased BTW.